Browsing by Autor "Amilcar Flores"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item type: Item , Human Congenital Infection With Trypanosoma cruzi Induces Phenotypic and Functional Modifications of Cord Blood NK Cells(Springer Nature, 2006) Emmanuel Hermann; Cristina Alonso‐Vega; Aurélie Berthe; Carine Truyens; Amilcar Flores; Marisol Córdova; Lorenzo Moretta; Faustino Torrico; Véronique M. Braud; Yves CarlierItem type: Item , Maternal Infection with Trypanosoma cruzi and Congenital Chagas Disease Induce a Trend to a Type 1 Polarization of Infant Immune Responses to Vaccines(Public Library of Science, 2009) Nicolás Dauby; Cristina Alonso‐Vega; Eduardo Suárez; Amilcar Flores; Emmanuel Hermann; Marisol Córdova; Tatiana Tellez; Faustino Torrico; Carine Truyens; Yves CarlierThese results show that: i) both maternal infection with T. cruzi and congenital Chagas disease do not interfere with responses to BCG, hepatitis B, diphtheria and tetanus vaccines in the neonatal period, and ii) the overcoming of immunological immaturity by T. cruzi infection in early life is not limited to the development of parasite-specific immune responses, but also tends to favour type 1 immune responses to vaccinal antigens.Item type: Item , Monocytes from Uninfected Neonates Born to Trypanosoma cruzi-Infected Mothers Display Upregulated Capacity to Produce TNF-α and to Control Infection in Association with Maternally Transferred Antibodies(Multidisciplinary Digital Publishing Institute, 2023) Amilcar Flores; Cristina Alonso‐Vega; Emmanuel Hermann; Mary‐Cruz Torrico; Nair Alaide Montaño Villarroel; Faustino Torrico; Yves Carlier; Carine TruyensActivated monocytes/macrophages that produce inflammatory cytokines and nitric oxide are crucial for controlling <i>Trypanosoma cruzi</i> infection. We previously showed that uninfected newborns from <i>T. cruzi</i> infected mothers (M+B- newborns) were sensitized to produce higher levels of inflammatory cytokines than newborns from uninfected mothers (M-B- newborns), suggesting that their monocytes were more activated. Thus, we wondered whether these cells might help limit congenital infection. We investigated this possibility by studying the activation status of M+B- cord blood monocytes and their ability to control <i>T. cruzi</i> in vitro infection. We showed that M+B- monocytes have an upregulated capacity to produce the inflammatory cytokine TNF-α and a better ability to control <i>T. cruzi</i> infection than M-B- monocytes. Our study also showed that <i>T. cruzi</i>-specific Abs transferred from the mother play a dual role by favoring trypomastigote entry into M+B- monocytes and inhibiting intracellular amastigote multiplication. These results support the possibility that some M+B- fetuses may eliminate the parasite transmitted in utero from their mothers, thus being uninfected at birth.Item type: Item , [Serum levels for IgM and IgA antibodies to anti-trypanosoma cruzi in samples of blood from newborns from mothers with positive serology for Chagas disease].(National Institutes of Health, 2005) Patricia Rodríguez; Carine Truyens; Cristina Alonso‐Vega; Amilcar Flores; Marisol Córdova; Eduardo Suárez; Faustino Torrico; Yves CarlierThis study compares the levels of specific antibodies IgM and IgA for Chagas in samples of blood from newborns. Three groups of cord blood samples have been analysed: a group of 42 samples from newborns, displaying positive parasitemia, of seropositive mothers (M+B+), 68 samples from newborns with negative parasitemia whose mothers were seropositive (M+B-) and a group of 45 control newborns coming from mothers with negative serology for Chagas. From the 42 M+B+ samples with congenital Chagas disease, 81 and 82.9% displayed detectable levels of IgM and IgA antibodies, respectively In the M+B- group, 70.6 and 33.8% presented antibodies of IgM and IgA classes, respectively, whereas in the control group M-B-, we detected 6% and 11.1% of IgM and IgA antibodies, respectively. The calculated sensitivity of detection of congenital cases using IgM or IgA antibodies was of 82.9% and 80.9% respectively, whereas the specificity of detection was of 29.4% for IgM antibodies and of 66.1% for IgA antibodies.